# The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine

> **NCT01736709** · PHASE4 · COMPLETED · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 202 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** 2012-2013 trivalent seasonal influenza vaccine

## Key facts

- **NCT ID:** NCT01736709
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-04
- **Final completion:** 2013-05
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2013-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736709, "The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01736709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*